DENTSPLY SIRONA Inc. (NASDAQ:XRAY) SVP Lisa Yankie sold 1,903 shares of the stock in a transaction that occurred on Friday, November 19th. The shares were sold at an average price of $52.63, for a total transaction of $100,154.89. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
NASDAQ:XRAY opened at $51.26 on Thursday. The company has a quick ratio of 1.13, a current ratio of 1.60 and a debt-to-equity ratio of 0.38. The company has a market cap of $11.21 billion, a P/E ratio of 26.98, a P/E/G ratio of 0.85 and a beta of 0.88. DENTSPLY SIRONA Inc. has a fifty-two week low of $50.54 and a fifty-two week high of $69.54. The firm’s 50 day moving average is $57.08 and its two-hundred day moving average is $61.36.
DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, November 4th. The medical instruments supplier reported $0.68 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.03. The company had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.02 billion. DENTSPLY SIRONA had a net margin of 9.85% and a return on equity of 13.05%. DENTSPLY SIRONA’s revenue was up 19.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.67 earnings per share. Research analysts forecast that DENTSPLY SIRONA Inc. will post 2.89 earnings per share for the current fiscal year.
XRAY has been the topic of a number of analyst reports. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $68.00 target price on the stock in a research report on Thursday, July 29th. Barrington Research raised their target price on shares of DENTSPLY SIRONA from $77.00 to $79.00 and gave the stock an “outperform” rating in a research report on Friday, August 6th. TheStreet upgraded shares of DENTSPLY SIRONA from a “c+” rating to a “b” rating in a research report on Thursday, August 5th. Finally, HC Wainwright decreased their target price on shares of DENTSPLY SIRONA from $72.00 to $66.00 and set a “neutral” rating on the stock in a research report on Monday, August 9th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, DENTSPLY SIRONA has a consensus rating of “Hold” and a consensus target price of $67.57.
About DENTSPLY SIRONA
Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.
Featured Article: Calculate Your Return on Investment (ROI)
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.